By Michael Erman and Mrinalika Roy Feb 3 (Reuters) - Pfizer on Tuesday released trial data on a high-profile obesity drug ...

Pfizer is positioning its experimental medicine as a competitor to Eli Lilly's (LLY) Zepbound and Novo Nordisk's (NVO) Wegovy, which are both weekly GLP-1 injections, after it re-entered the ...

The pharmaceutical giant (PFE) said two doses from a Phase 2b study of the once-a-month injection demonstrated weight reduction of 10% and 12.3% after 28 weeks in adults with obesity or overweight ...

Maryland 2026 men’s college lacrosse preview: Johns Hopkins enters key year ...

In the 11.2 over, Kagiso Rabada delivers a wide to Shimron Hetmyer! South Africa seems to be faltering in their accuracy, as ...